Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial

Published:2007-12 Issue:12 Volume:6 Page:1054-1062
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Diener Hans-Christoph,Agosti Reto,Allais Gianni,Bergmans Paul,Bussone Gennaro,Davies Brendan,Ertas Mustafa,Lanteri-Minet Michel,Reuter Uwe,Del Río Margarita Sánchez,Schoenen Jean,Schwalen Susanne,van Oene Joop

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference20 articles.

1. Migraine prevalence, disease burden, and the need for preventive therapy;Lipton;Neurology,2007

2. One-year prevalence of migraine in Sweden: a population-based study in adults;Dahlof;Cephalalgia,2001

3. Prevalence and burden of migraine in the United States: data from the American Migraine Study II;Lipton;Headache,2001

4. French guidelines for the diagnosis and management of migraine in adults and children;Geraud;Clin Ther,2004

5. EFNS guideline on the drug treatment of migraine—report of an EFNS task force;Evers;Eur J Neurol,2006

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine;Cephalalgia;2024-09

2. Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury;Cephalalgia;2024-03

3. Evidence-based preventive treatment of migraine;Handbook of Clinical Neurology;2024

4. Preventive treatment of migraine: Non-specific oral agents;Handbook of Clinical Neurology;2024

5. European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate;The Journal of Headache and Pain;2023-10-10